Molecular pathology and genetics of pancreatic endocrine tumours.
about
The structure and function of NKAIN2-a candidate tumor suppressorCommon germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsPML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cellsLoss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms.Histone variant H3.3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeresPharmacotherapy of Zollinger-Ellison syndrome.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesA woman with metastatic pancreatic neuroendocrine tumor.RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.Translational research in neuroendocrine tumors: pitfalls and opportunities.Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium.
P2860
Q26771844-242E054A-FE04-4FBD-BD9C-C17D6DC8BD9BQ28397098-D1B1F1F3-535A-412D-9E7F-D50B3B590EBFQ28587544-4816519C-8A47-4531-B0FF-09C419CD352EQ34000638-4CFE5620-1262-4225-BEDF-786307323E9FQ34490850-C34FB84C-4653-4341-B5D0-A5F8432FEA54Q36632665-134DE5DD-BDA9-4381-8310-3F9B907D626AQ37125550-ECE37F97-94C9-4445-8430-8643C5383717Q37584857-0BE446DC-3626-40AC-9EEC-943CA4A2FDDDQ37628945-BE0A746F-C590-4B0E-872A-86D403498C8EQ38129331-70525B0B-0994-406F-A4AA-2FBB07E13287Q38331666-994D6A8A-4A07-4B2C-9512-455FCB2B86CBQ38457942-98EA0F87-C903-4180-9B02-E9DB0A50F0FBQ38855698-143A3FDA-E187-4CB3-87C9-719B247310F6Q38958002-76DAE25F-A6DA-44B1-9FE1-371AF1BF5D50Q39036247-FE3E9AF5-C0B4-43BE-B32B-E7603D2733EEQ41028465-6D562C1B-51B5-4B37-B460-184D9BCDAA09Q48520101-EB7C7A47-8E1B-44E4-AF3D-8EF298604ED0
P2860
Molecular pathology and genetics of pancreatic endocrine tumours.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular pathology and genetics of pancreatic endocrine tumours.
@ast
Molecular pathology and genetics of pancreatic endocrine tumours.
@en
Molecular pathology and genetics of pancreatic endocrine tumours.
@nl
type
label
Molecular pathology and genetics of pancreatic endocrine tumours.
@ast
Molecular pathology and genetics of pancreatic endocrine tumours.
@en
Molecular pathology and genetics of pancreatic endocrine tumours.
@nl
prefLabel
Molecular pathology and genetics of pancreatic endocrine tumours.
@ast
Molecular pathology and genetics of pancreatic endocrine tumours.
@en
Molecular pathology and genetics of pancreatic endocrine tumours.
@nl
P2093
P356
P1476
Molecular pathology and genetics of pancreatic endocrine tumours
@en
P2093
Gianfranco Delle Fave
Matteo Piciucchi
Robert T Jensen
Roberto Valente
Stefano Festa
P304
P356
10.1530/JME-12-0069
P577
2012-06-26T00:00:00Z